THE WAYNE-STATE-UNIVERSITY EXPERIENCE WITH ADJUVANT CHEMOTHERAPY OF HEAD AND NECK-CANCER

[1] ALKOURAINY K, 1985, P AM ASSOC CANC RES, V26, P164

[2] CHEMOTHERAPEUTIC MANAGEMENT OF HEAD AND NECK-CANCER [J]. CANCER AND METASTASIS REVIEWS, 1987, 6 (03) : 181 - 198

[3] ALSARRAF M, 1988, SEMIN ONCOL, V15, P70

[4] CHEMOTHERAPY STRATEGIES IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK [J]. CRC CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY, 1984, 1 (04): : 323 - 355

[5] ALSARRAF M, 1987, CANCER-AM CANCER SOC, V59, P259, DOI 10.1002/1097-0142(19870115)59:2<259::AID-CNCR2820590214>3.0.CO

[6] 2-1

[7] ALSARRAF M, 1981, P AM ASSOC CANC RES, V22, P428

[8] ALSARRAF M, 1982, P AM ASSOC CANC RES, V23, P134

[9] ALSARRAF M, 1985, P AN M AM SOC CLIN, V4, P141

[10] ALSARRAF M, 1981, ADJUVANT THERAPY CAN, V3, P145

[1] ALKOURAINY K, 1985, P AM ASSOC CANC RES, V26, P164

[2] CHEMOTHERAPEUTIC MANAGEMENT OF HEAD AND NECK-CANCER [J]. CANCER AND METASTASIS REVIEWS, 1987, 6 (03) : 181 - 198

[3] ALSARRAF M, 1988, SEMIN ONCOL, V15, P70

[4] CHEMOTHERAPY STRATEGIES IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK [J]. CRC CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY, 1984, 1 (04): : 323 - 355

[5] ALSARRAF M, 1987, CANCER-AM CANCER SOC, V59, P259, DOI 10.1002/1097-0142(19870115)59:2<259::AID-CNCR2820590214>3.0.CO

[6] 2-1

[7] ALSARRAF M, 1981, P AM ASSOC CANC RES, V22, P428

[8] ALSARRAF M, 1982, P AM ASSOC CANC RES, V23, P134

[9] ALSARRAF M, 1985, P AN M AM SOC CLIN, V4, P141

[10] ALSARRAF M, 1981, ADJUVANT THERAPY CAN, V3, P145